Health Care - Spark Newswire

4 minute read

Big Tech Is More Important Than Ever With Alphabet Even Reaching New Horizons

Today, 7:58 AM

With the latest earnings, it became clear that the pandemic push was just the beginning for Big Tech as Apple (NASDAQ: AAPL), Google owner Alphabet (NASDAQ: GOOG), Amazon (NASDAQ:

AAPL

1 minute read

Bristol Myers’ Opdivo-Yervoy Combo Approved In Europe, Canada For Malignant Pleural Mesothelioma

By Vandana Singh

Today, 7:58 AM

The regulatory authorities in Europe and Canada have approved Bristol Myers Squibb & Co’s (NYSE:BMY) Opdivo (nivolumab) plus Yervoy (ipilimumab) for the first-line treatment…

BMY

1 minute read

Mereo’s Alvelestat Shows Encouraging Biomarker Data In Bronchiolitis Obliterans Syndrome

By Vandana Singh

Today, 7:58 AM

Mereo BioPharma Group plc (NASDAQ:MREO) has announced data from an interim analysis of an investigator-initiated study of alvelestat, in patients with…

MREO

1 minute read

Seres Therapeutics Gets FDA Green Signal to Start SER-155 Human Trials

By Vandana Singh

Today, 7:58 AM

The FDA has signed off Seres Therapeutics Inc’s (NASDAQ:MCRB) Investigational New Drug (IND) application for SER-155 to initiate Phase 1 trial.…

MCRB

1 minute read

BeyondSpring’s Plinabulin US Application for Chemo-Induced Neutropenia Under Review

By Vandana Singh

Today, 7:58 AM

The FDA has accepted for review BeyondSpring Inc’s (NASDAQ:BYSI) marketing application seeking approval for the use of plinabulin in combination with…

BYSI

1 minute read

Akebia Therapeutics Stock Jumps as FDA Accepts Vadadustat US Application in CKD-Related Anemia

By Vandana Singh

Today, 7:58 AM

Akebia Therapeutics Inc (NASDAQ:AKBA) and its collaborator Otsuka Holdings (OTC:OTSKY) have announced that the FDA has accepted to review vadadustat’s marketing application for…

AKBA

1 minute read

Sanofi Stops Venglustat Development In Rare Genetic Kidney Disorder

By Vandana Singh

Today, 7:58 AM

Sanofi SA (NASDAQ:SNY) has halted the clinical program of venglustat in autosomal dominant polycystic kidney disease (ADPKD). Although the safety profile…

SNY

1 minute read

CDC Says 166,388,129 Individuals Have Received At Least One Dose Of COVID-19 Vaccine As Of May 28

By Bill Haddad

Today, 7:58 AM

-Reuters

BNTX

1 minute read

Amgen’s First KRAS-Targeted Therapy, Lumakras Scores FDA Approval For Lung Cancer

By Vandana Singh

Today, 7:58 AM

The FDA has given accelerated approval to Amgen Inc’s (NASDAQ:AMGN) Lumakras (sotorasib) for non-small cell lung cancer (NSCLC) patients harboring kras mutation.…

AMGN

1 minute read

CDC In Guidance For Camps, Says Mask Use Indoors Is Strongly Encouraged For People Who Are Not Fully Vaccinated Including Children

By Bill Haddad

Today, 7:58 AM

-Reuters

APT